GrowthXP Neo to incorporate Sweden’s new bilirubin guidelines for neonatal care
By Tags:

PC PAL is pleased to announce that GrowthXP Neo, our specialist solution for visualising neonatal data, will be updated to incorporate the new national Swedish guidelines for neonatal hyperbilirubinemia, published in 2025 (https://neo.barnlakarforeningen.se/riktlinjer-vardprogram/metabolism-hematologi/metabolism-hematologi/ ) Hyperbilirubinemia, the cause of newborn jaundice, affects more than half of all babies. While often harmless, in some cases bilirubin levels may…

New LMSz Method Enables Gene-Specific Growth Charts for Rare Genetic Disorders
By

Growth monitoring is one of the cornerstones of paediatric practice, but standard growth charts often fail to reflect the trajectories of children with rare, genetic disorders. These children frequently plot at extreme centiles, with the result that plotting on standard charts can be misleading and compromise management. A new study presented at the British Society…

Experts challenge BMI as sole measure of clinical obesity
By

A landmark report from an international Commission of experts, published in The Lancet Diabetes & Endocrinology (Rubino et al., 2025: https://doi.org/10.1016/S2213-8587(24)00316-4), calls for a re-evaluation of Body Mass Index (BMI) as a standalone measure for assessing clinical obesity. The Commission highlights the limitations of BMI, noting that it can both overestimate and underestimate adiposity, as…